Given the significant induction of Angpt-2 and its association with the coagulopathy of critical illness via inhibition of Tie2 (23), we tested whether pharmacologic activation of Tie2 could reverse thromboinflammatory gene expression triggered by COVID-19 plasma. This evidence concerns the gene TEK and COVID-19.